| Metric | Q1 FY27 | Q4 FY26 | Q1 FY26 |
|---|---|---|---|
| Revenue from operations | 380000.0 | 375000.0 | 900000.0 |
| Total income | 380000.0 | 375000.0 | 900000.0 |
| Profit before exceptional items & tax | 146162.0 | 15624.0 | 246531.0 |
| Profit before tax | 146162.0 | 15624.0 | 246531.0 |
| Net profit | 146162.0 | -81745.0 | 246531.0 |
| Operating margin | 38.5% | 4.2% | 27.4% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Net profit, year on year | -40.70% |
|---|---|
| Revenue, year on year | -57.80% |
Source
Read the filing ↗
BSE results filing, NSE: GVBL. Figures extracted from the filing.
Genomic Valley Biotech Ltd: key numbers
- Share price
- ₹27.65
- Market cap
- ₹8.45 Cr
- Revenue (annual)
- ₹0.27 Cr
- Net profit (annual)
- ₹0.03 Cr
- P/E (TTM)
- 415.2×Sector 50.4×
- Promoter holding
- 46.06%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Genomic Valley Biotech Ltd
All →
17:46 IST
BSE
Financial Results
Genomic Valley Biotech Q4 FY26 Results: Net Loss of ₹81,745 Cr, Loss Narrows
Genomic Valley Biotech Ltd reported revenue from operations of ₹375,000 Cr (-85.8% YoY) and a net loss of ₹81,745 Cr for Q4 FY26.
- Key figure
- Net loss ₹81,745 Cr